Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 1725; doi:10.1093/annonc/mdl441
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

AK Ng and PM Mauch

The impact of treatment on the risk of second malignancy after Hodgkin's disease
Ann Oncol 17: 1727-1729; doi:10.1093/annonc/mdl433
[Extract] [Full Text] [PDF] [Request Permissions]

F Kerr and D Kerr

Do we bear any moral responsibility for improving cancer care in Africa?
Ann Oncol 17: 1730-1731; doi:10.1093/annonc/mdl442
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

C Susini and L Buscail

Rationale for the use of somatostatin analogs as antitumor agents
Annals of Oncology Advance Access published on June 26, 2006
Ann Oncol 17: 1733-1742; doi:10.1093/annonc/mdl105
[Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]

F Mornex and N Girard

Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1743-1747; doi:10.1093/annonc/mdl117
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

hematologic malignancies:

J Franklin, A Pluetschow, M Paus, L Specht, A-P Anselmo, A Aviles, G Biti, T Bogatyreva, G Bonadonna, C Brillant, E Cavalieri, V Diehl, H Eghbali, C Fermé, M Henry-Amar, R Hoppe, S Howard, R Meyer, D Niedzwiecki, S Pavlovsky, J Radford, J Raemaekers, D Ryder, P Schiller, S Shakhtarina, P Valagussa, J Wilimas, and J Yahalom

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
Annals of Oncology Advance Access published on September 19, 2006
Ann Oncol 17: 1749-1760; doi:10.1093/annonc/mdl302
[Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]

M Hoffmann, S Wöhrer, A Becherer, A Chott, B Streubel, K Kletter, and M Raderer

18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1761-1765; doi:10.1093/annonc/mdl295
[Abstract] [Full Text] [PDF] [Request Permissions]

R Baz, E Walker, MA Karam, TK Choueiri, RA Jawde, K Bruening, J Reed, B Faiman, Y Ellis, C Brand, G Srkalovic, S Andresen, R Knight, J Zeldis, and MA Hussein

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1766-1771; doi:10.1093/annonc/mdl313
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

A Goldhirsch, AS Coates, RD Gelber, JH Glick, B Thürlimann, and H-J Senn On behalf of the St Gallen Expert Panel Members

First—select the target: better choice of adjuvant treatments for breast cancer patients
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 17: 1772-1776; doi:10.1093/annonc/mdl398
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

MG Leining, S Gelber, R Rosenberg, M Przypyszny, EP Winer, and AH Partridge

Menopausal-type symptoms in young breast cancer survivors
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1777-1782; doi:10.1093/annonc/mdl299
[Abstract] [Full Text] [PDF] [Request Permissions]

R Clèries, J Ribes, L Esteban, JM Martinez, and JM Borràs

Time trends of breast cancer mortality in Spain during the period 1977–2001 and Bayesian approach for projections during 2002–2016
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1783-1791; doi:10.1093/annonc/mdl303
[Abstract] [Full Text] [PDF] [Request Permissions]

C Mathias, CM Cardeal Mendes, E Pondé de Sena, E Dias de Moraes, C Bastos, MI Braghiroli, G Nuñez, R Athanazio, L Alban, HCF Moore, and A del Giglio

An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1792-1796; doi:10.1093/annonc/mdl304
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

A Bamias, Z Yu, PM Weinberger, S Markakis, D Kowalski, RL Camp, DL Rimm, MA Dimopoulos, and A Psyrri

Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with ß-catenin levels and outcome in patients with epithelial ovarian cancer
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1797-1802; doi:10.1093/annonc/mdl310
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

VE Lemmens, I van Lijnschoten, ML Janssen-Heijnen, HJ Rutten, CD Verheij, and J-WW Coebergh

Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1803-1809; doi:10.1093/annonc/mdl312
[Abstract] [Full Text] [PDF] [Request Permissions]

S Popat, Z Chen, D Zhao, H Pan, N Hearle, I Chandler, Y Shao, W Aherne, and RS Houlston

A prospective, blinded analysis of thymidylate synthase and p53 expression as prognostic markers in the adjuvant treatment of colorectal cancer
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1810-1817; doi:10.1093/annonc/mdl301
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

P Ceppi, M Volante, S Novello, I Rapa, KD Danenberg, PV Danenberg, A Cambieri, G Selvaggi, S Saviozzi, R Calogero, M Papotti, and GV Scagliotti

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1818-1825; doi:10.1093/annonc/mdl300
[Abstract] [Full Text] [PDF] [Request Permissions]

melanoma:

A Schmittel, M Schmidt-Hieber, P Martus, NE Bechrakis, R Schuster, JM Siehl, MH Foerster, E Thiel, and U Keilholz

A randomized phase II trial of gemcitabine plus treosulfan versus treosulfan alone in patients with metastatic uveal melanoma
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1826-1829; doi:10.1093/annonc/mdl309
[Abstract] [Full Text] [PDF] [Request Permissions]

P Kiewe, NE Bechrakis, A Schmittel, P Ruf, H Lindhofer, E Thiel, and D Nagorsen

Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1830-1834; doi:10.1093/annonc/mdl305
[Abstract] [Full Text] [PDF] [Request Permissions]

H Gogas, A Polyzos, I Stavrinidis, K Frangia, D Tsoutsos, P Panagiotou, C Markopoulos, O Papadopoulos, D Pectasides, M Mantzourani, M Middleton, G Vaiopoulos, and G Fountzilas

Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 17: 1835-1841; doi:10.1093/annonc/mdl311
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

L Richiardi, D Mirabelli, R Calisti, A Ottino, A Ferrando, P Boffetta, and F Merletti

Occupational exposure to diesel exhausts and risk for lung cancer in a population-based case–control study in Italy
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 17: 1842-1847; doi:10.1093/annonc/mdl307
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

TR Halfdanarson, SN Markovic, U Kalokhe, and M Luppi

A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1849-1850; doi:10.1093/annonc/mdl139
[Extract] [Full Text] [PDF] [Request Permissions]

M-C Etienne-Grimaldi, A Cayre, F Penault-Llorca, M Francoual, J-L Formento, D Benchimol, A Bourgeon, and G Milano

EGFR expression in colon cancer: a break in the clouds
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1850-1851; doi:10.1093/annonc/mdl138
[Extract] [Full Text] [PDF] [Request Permissions]

S Yoon, D Schmassmann-Suhijar, M Zuber, P Konietzny, and A Schmassmann

Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta
Annals of Oncology Advance Access published on June 15, 2006
Ann Oncol 17: 1851-1852; doi:10.1093/annonc/mdl140
[Extract] [Full Text] [PDF] [Request Permissions]

O Pichelmayer, B Gruenberger, C Zielinski, and M Raderer

Bevacizumab is active in malignant effusion
Annals of Oncology Advance Access published on June 21, 2006
Ann Oncol 17: 1853; doi:10.1093/annonc/mdl143
[Extract] [Full Text] [PDF] [Request Permissions]

O Mir, J Alexandre, S Ropert, and F Goldwasser

Oxaliplatin in inoperable or metastatic bladder cancer
Annals of Oncology Advance Access published on July 21, 2006
Ann Oncol 17: 1853-1854; doi:10.1093/annonc/mdl157
[Extract] [Full Text] [PDF] [Request Permissions]

A Berruti, M Tucci, D Generali, A Mosca, M Ardine, F Vana, and L Dogliotti

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation
Annals of Oncology Advance Access published on August 25, 2006
Ann Oncol 17: 1854-1855; doi:10.1093/annonc/mdl181
[Extract] [Full Text] [PDF] [Request Permissions]

Indexes:

subject index
Ann Oncol 17: 1857-1871; doi:10.1093/annonc/mdl470
[PDF] [Request Permissions]

author index
Ann Oncol 17: 1873-1885; doi:10.1093/annonc/mdl471
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.